What is the preferred biopsy method, shave biopsy or excisional biopsy, for a patient with a suspected melanoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Preferred Biopsy Method for Suspected Melanoma

For suspected melanoma, perform a narrow excisional (complete) biopsy with 1-3 mm margins as the preferred diagnostic approach, which can be accomplished through elliptical excision, punch excision, or deep shave/saucerization technique that extends below the anticipated depth of the lesion. 1

Primary Recommendation: Excisional Biopsy

The American Academy of Dermatology establishes narrow excisional biopsy as the gold standard because it:

  • Provides complete tissue sampling of the entire breadth of the lesion 1
  • Prevents transection at the base, ensuring accurate Breslow thickness measurement 1, 2
  • Allows for proper pathological staging without risk of understaging 1
  • Eliminates the need for re-excision in most cases 1

The excisional approach should encompass the entire lesion with 1-3 mm margins and sufficient depth to capture tissue below the anticipated plane of the tumor. 1 This can be achieved through fusiform/elliptical excision, punch excision (when removing the entire lesion), or deep shave/saucerization removal. 1

When Shave Biopsy is Acceptable

Deep shave biopsy (saucerization technique) is acceptable when performed to adequate depth below the lesion, particularly in these scenarios:

  • Low clinical suspicion for melanoma 1
  • Melanoma in situ, especially lentigo maligna type, where broad shave biopsy optimizes diagnostic sampling 1
  • Anatomically challenging locations where complete excision is difficult 1

Critical Distinction: Deep vs Superficial Shave

The depth of shave biopsy is paramount. Superficial shave biopsies should be avoided for suspected invasive melanoma because they underestimate Breslow thickness and clinical stage. 2 However, deep shave biopsies extending into subcutaneous fat are more accurate than punch biopsies for melanomas less than 2 mm thick. 3

Research demonstrates that when performed appropriately by experienced practitioners, shave biopsies are accurate in 97% of cases, with only 3% requiring upstaging after wide excision. 4 Deep shave biopsies showed 88% accuracy in capturing true Breslow depth. 3

When Partial Biopsy is Acceptable

Incisional or partial sampling is acceptable only in highly select circumstances and should be performed by specialists within a skin cancer multidisciplinary team, not in primary care settings: 1, 2, 5

  • Facial location (especially lentigo maligna) 1
  • Acral locations (palms, soles, subungual) 1
  • Very large lesions where complete excision is not initially feasible 1
  • Anatomically sensitive areas requiring tissue preservation 1

Critical Pitfalls to Avoid

Do not perform superficial shave biopsies when invasive melanoma is suspected, as they compromise accurate Breslow thickness measurement and lead to understaging. 2

Avoid punch biopsies as the primary diagnostic method for suspected melanoma except in the specific circumstances listed above, because they:

  • Have high upstaging rates when residual tumor is found at wide excision 6
  • Result in larger mean wide excision areas compared to other biopsy types 6
  • Risk missing the thickest portion of the lesion through partial sampling 7
  • Prevent accurate pathological staging 7

Research shows that both shave and punch biopsies demonstrate significantly more positive margins (peripheral and deep) compared to excisional biopsy, with higher rates of finding residual tumor at wide excision. 6

Algorithm for Biopsy Selection

Step 1: Assess lesion characteristics and location

  • If feasible for complete removal → Perform narrow excisional biopsy with 1-3 mm margins 1, 2
  • If complete removal not feasible → Proceed to Step 2 1

Step 2: Determine if special circumstances apply

  • Facial lentigo maligna → Broad shave biopsy or incisional biopsy by specialist 1
  • Acral location → Incisional biopsy by specialist experienced in nail/acral anatomy 1, 7
  • Very large lesion → Incisional biopsy of thickest portion by specialist 1
  • Low suspicion → Deep shave biopsy acceptable 1

Step 3: If initial biopsy is inadequate for microstaging

  • Perform narrow margin re-excision before proceeding to definitive wide local excision 1, 5
  • Do not perform wide excision if initial specimen already meets criteria for sentinel lymph node biopsy consideration 1

Essential Pathology Requirements

Regardless of biopsy technique, ensure the pathologist receives and reports: 1

  • Breslow thickness to nearest 0.1 mm 1
  • Presence or absence of ulceration 1
  • Mitotic rate per mm² 1
  • Peripheral and deep margin status 1
  • Clark level (optional for Breslow >1 mm) 1

Impact on Clinical Outcomes

Importantly, biopsy type does not impact sentinel lymph node biopsy accuracy (98.5%), tumor recurrence rates, or disease-specific survival when performed appropriately. 6 The finding of residual tumor at wide excision may impact survival on univariate analysis but not on multivariate analysis. 6 Historical data confirms that wide excision as the initial diagnostic procedure does not improve survival compared to other biopsy methods followed by definitive surgery. 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Biopsy Guidelines for Suspected Melanoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Shave biopsy is a safe and accurate method for the initial evaluation of melanoma.

Journal of the American College of Surgeons, 2011

Guideline

Punch Biopsy and Wide Excision for Suspected Melanoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Management of Suspected Melanoma on the Sole

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.